07 Jan 2001

Algesal aerosol - España

Updated: 07 Jan 2001

Algesal aerosol espuma 60 g

Tratamiento de lesiones músculo-esqueléticas acompañadas de dolor y/o inflamación: bursitis, tendinitis, contusiones, luxaciones, torceduras.

Algesal aerosol Description, Presentation and Dosage

Algesal aerosol Description

Algesal aerosol Drug Class Description

Antiinflamatorios topicos sin corticoides

Algesal aerosol Drug Description

SPRAY-AEROSOL

Algesal aerosol Presentation

Algesal aerosol Presentation

Tópica: Aplicar sobre la zona afectada 3-4 veces al día, practicando un ligero masaje para facilitar la absorción.

Algesal aerosol Manufacturer

SOLVAY PHARMA

Related Learning Zones

LAL-D Knowledge Centre

LAL-D Knowledge Centre

The Lysosomal Acid Lipase (LAL) Deficiency Knowledge Centre contains a range of accurate, informative clinical content for healthcare professionals. The disease awareness section presents epidemiology, pathophysiology and diagnosis information, among others. The treatment section details the drug characteristics, safety and efficacy of sebelipase alfa – the first and only licenced treatment for LAL deficiency. The resources section contains further clinical content including a video channel presenting expert opinions on diagnostic approach and current prognosis.

Developed by EPG Health Media (Europe) Ltd for epgonline.org, in collaboration and with content provided by Alexion Pharma GmbH

Obesity CME series

Obesity CME series

This European Obesity Initiative CME series contains three online modules, which are ideal for healthcare professionals looking to widen their understanding of obesity as a serious medical illness. Each module is EACCME-accredited and free to complete. Successful completion of the series will earn participants a combined total of 5 European CME credits (ECMECs).

Algesal aerosol Dosage

Algesal aerosol Precautions, Reactions and Contraindications

Algesal aerosol Special Precautions

Algesal aerosol Adverse Reactions

Algesal aerosol Adverse Reactions

Excepcionalmemte, eritema y escozor en el lugar de aplicación.

Related Drugs - Sistema nervioso central

Back to top